Skip to content

Anxiety: all studies

Page 477 of 773: studies 4,761 to 4,770 of 7,721, newest first. Back to the anxiety overview

Research

Associations between self‐reported parasomnias and psychiatric illness in 370,000 patients with sleep disorders

Psychiatry and Clinical Neurosciences August 30, 2024 Umaer Hanif, Alyssa Cairns, Vincent Mysliwiec et al. 14 citations

AIM: To assess self-reported parasomnias in patients with sleep disorders and explore relationships with psychiatric illness, comorbidities, subjective sleep assessments, and polysomnographic study results. METHODS: Results from intake questionnaires and polysomnographic assessments, collected from 240 sleep centers across 30 US states between 2004 and 2019, were analyzed retrospectively. Of...

How Psychedelics Influence Brain Networks

August 30, 2024

Psychedelics can induce mystical experiences, with higher Mystical Experience Questionnaire scores correlating with greater therapeutic effects like reduced cravings and anxiety. Psychedelics disrupt the default mode network, which is implicated in psychiatric conditions and sense of self, potentially reducing negative self-referential thinking. Psychedelics may disrupt the claustrum, inducing...

A Multi-Center, Open-Label, Single-Arm Study to Investigate the Early Effectiveness of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Using a Mobile Self-Monitoring Application.

Pharmaceuticals August 30, 2024 Junhyung Kim, Seung-Hoon Lee, Cheolmin Shin et al. 8 citations

This study assesses the early effectiveness of esketamine nasal spray (ESK) in adults with treatment-resistant depression (TRD) 1 day after the first administration, as monitored through self-assessment via the mobile application, Esketamine Continuing Assessment for Relapse Prevention (EsCARe). In this multi-center, open-label, single-arm study, adults aged 18-65 years diagnosed with TRD after...

Psychedelic‐assisted therapy for palliative care within a home treatment setting: A case report

Clinical Case Reports August 30, 2024 Seragnoli Federico, Martignoni Geo, Martignoni Entela et al. 3 citations

Key Clinical Message This case study describes the feasibility and safety of psychedelic‐assisted therapy (PAT) as a home‐based intervention for a patient with throat cancer experiencing significant existential distress. The patient tolerated the intervention well. This case supports the feasibility and safety of PAT for patients with life‐threatening conditions in a home setting. Abstract...

DOI: 10.1002/ccr3.9305 (opens in new tab) Psychedelic therapy Home treatment Palliative care Psychedelic‐assisted therapy +4

Peduncular Hallucinosis: Clinical characteristics, etiology, and a case report

European Psychiatry August 27, 2024 J. Garde Gonzalez, A. Oliva Lozano, P. Herrero Ortega et al.

Introduction Visual hallucinations are a relatively common neurological complaint. Peduncular hallucinosis (PH) stands out as a distinct entity, characterized by complex visual hallucinations resulting from structural lesions in the brainstem or diencephalon. Objectives We aim to provide an overview of the clinical features, etiological factors, and management strategies associated with PH,...

A Randomized Clinical Trial Comparing the Effects of Mindfulness-Based and Cognitive Behavioral Therapy-Based Stress Reduction in Medical Students

European Psychiatry August 27, 2024 Aysegul Yay-Pence, Merve Coldur, Zumra Atalay et al.

Introduction Medical students face an enormous amount of stress (Dyrbye LN et al. Ann Intern Med 2008; 149: 334-41). They suffer from higher rates of depression, anxiety, and suicide compared to the general population. Despite experiencing more mental health problems, there is a lack of research exploring ways to improve their mental health. Although there are a few small sample studies...

The role of psilocybin in depressive disorders

Current Medical Research and Opinion August 23, 2024 Jadwiga Najib 1 citation

Depression is a serious psychiatric disorder with a high incidence of morbidity and mortality and psilocybin with psychotherapy has emerged as a promising potential in the treatment of depressive disorders. A review of psilocybin use in patients with depressive disorders is presented.A search was conducted investigating the use of psilocybin in patients with depressive disorders and treatment...

Psilocybin-assisted psychotherapy for existential distress: practical considerations for therapeutic application—a review

Annals of Palliative Medicine August 22, 2024 Arum Kim, Barley Halton, Akash Shah et al. 11 citations

Existential distress is commonly experienced by patients diagnosed with a life-threatening illness. This condition has been shown to adversely impact quality of life and is correlated with increased suicidal ideation and requests for hastened death. While palliative care teams are experienced in treating depression and anxiety, existential distress is a distinct clinical condition for which...

DOI: 10.21037/apm-24-35 (opens in new tab) Psilocybin Psychotherapist Existentialism Distress

Mindful breathing for cancer pain: efficacy of a single 20-minute session - a randomised controlled study.

BMJ Supportive & Palliative Care August 20, 2024 Seng Beng Tan, Chee Shee Chai, Diana Leh Ching Ng et al. 6 citations

Cancer pain is a prevalent and challenging symptom affecting a significant number of patients globally, with inadequate control remaining a substantial challenge despite advancements in pain management. Non-pharmacological interventions, including mindfulness-based approaches, have shown promise in alleviating cancer-related pain. This study aimed to explore the efficacy of a single session of...